News by region
A new showcase series is reshaping NHS-supplier engagement. Pioneers at the first NHS host brought together hundreds of staff organisation-wide, along with major tech companies and niche innovators in a single day, already inspiring 10 further NHS providers to follow in 2026. Highland has launched Elevate, a new health tech event series that is bringing [...]
LUMO Labs’ LUMO Fund has secured €6m from Spain’s state-backed investment arm SETT to support early-stage startups across Spain and Europe. The €100m LUMO Fund is a multi-stage venture capital fund covering pre-seed to Series A investments. It plans to invest in around 30 to 35 startups over the next four years. The fund also [...]
AI health platform Qura has raised €1.5m in pre-seed funding to support its plans to improve how non-emergency health conditions are managed across Europe. The funding will be used to expand hiring across medical, engineering and operations teams, invest in digital marketing and community-led growth, advance Qura’s AI health intelligence capabilities and prepare for expansion [...]
MyWay Digital Health has secured £3m in funding to scale its diabetes management platform, which is used across several NHS regions. The Edinburgh-based company, spun out of the University of Dundee in 2017, employs 30 staff across Dundee, Edinburgh and London. It develops data-driven technology to support the management of long-term conditions, with a particular [...]
NHS England has introduced a new depreciation timeline for CIS1, requiring trusts to move completely to CIS2 by 28 February 2027, when access to CIS1 will be removed. Andrew Harrison, director, product management - international at Imprivata, discusses the drive for more secure access to electronic patient record systems that is affecting hospitals in the [...]
Ease Health has launched with US$41m in early-stage funding to expand adoption of its behavioural health software platform among large providers treating mental health and substance use conditions. The New York-based startup has developed a platform that combines admissions processing, patient management and billing tools for behavioural health providers. Many providers rely on two separate [...]
Generate:Biomedicines has raised US$400m in the year’s biggest biotech IPO so far, with proceeds earmarked for clinical trials and R&D on its artificial intelligence platform. The drug developer, which focuses on immunology and inflammation as well as oncology, priced shares at US$16 and began trading on the Nasdaq Global Market under the symbol GENB. [...]
Alcidion today announces that Miya Precision Concept Detection has been included on the Australian Register of Therapeutic Goods (ARTG – #522634) as a Class 1 Medical Device. The capability has also been successfully registered as a Class 1 Medical Device with the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom. Concept Detection [...]
By Sanius Health Gene therapy has now moved decisively from scientific ambition to clinical reality, and in doing so, it has redefined what is possible for patients living with severe genetic conditions such as sickle cell disease, where curative intent is no longer a distant aspiration but a regulated, deployable therapeutic pathway. What we are [...]
By John Romano, co-founder & chief strategy Officer, Gifthealth For pharmacists, a daily challenge is not just dispensing medication – it is managing the complex, often chaotic, journey of patients with gastrointestinal (GI) diseases. More than 60 million people in the US are affected by digestive diseases. Yet many patients struggle to effectively access life-changing [...]
